CellWell record HH-237215
Lipid and High-Density Lipoprotein (HDL) Subfraction Changes in Premenopausal and Postmenopausal Women With Breast Cancer Receiving Hormonal Therapy
Nikolakopoulou A; Nastos K; Papakonstantinou D; Stavrati KE; Michalaki V; Koutroulis G; Dafnios N; Papakonstantinou I; Papadimitriou C
Cureus ยท 2026
In plain language
Premenopausal women receiving tamoxifen demonstrated improved lipid profiles with increased HDL-2 particles, while postmenopausal women on aromatase inhibitors showed worsening lipid profiles and HDL composition.
- Evidence
- Emerging
- Design
- Primary research (design unspecified)
Cite this record: https://thecellwell.org/studies/HH-237215
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.